Fingolimod is an immunomodulator used to treat multiple sclerosis (MS) and COVID-19 in hospitalized patients. It works by preventing lymphocytes from reaching the central nervous system, thereby reducing inflammation and nerve damage. Fingolimod is effective in managing MS symptoms and may have a role in treating COVID-19. In summary, Fingolimod is beneficial for patients with MS and severe COVID-19.
Fingolimod binds to sphingosine-1-phosphate receptors, preventing lymphocyte egress from lymph nodes and reducing CNS inflammation.